Concepedia

Steve Boudewijns

SB

Statistics

Publications

10

Citations

284

H-Index

10

Active since

2011

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

Radboud Institute for Molecular Life Sciences

Amsterdam UMC Location University of Amsterdam

Institute of Cancer Research

Steve Boudewijns is an author at Radboud University Nijmegen specializing in medicine, immunotherapy, and vaccination.

ORCID

Top concepts

Publications per year

2011–2021

10

Publications

10

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

Steve Boudewijns, Martine Bloemendal, Nienke de Haas et al. · Cancer Immunology Immunotherapy · 2020 · 58 citations · Full text

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma

Kalijn F. Bol, Thomas van den Bosch, Gerty Schreibelt et al. · Ophthalmology · 2016 · 47 citations · Full text

, , +4

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients

Steve Boudewijns, Harm Westdorp, Rutger H.T. Koornstra et al. · Journal of Immunotherapy · 2016 · 32 citations · Full text

, , +19

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

Steve Boudewijns, Martine Bloemendal, Winald R. Gerritsen et al. · Human Vaccines & Immunotherapeutics · 2016 · 25 citations · Full text

, , +20

Immunological responses to adjuvant vaccination with combined CD1c <sup>+</sup> myeloid and plasmacytoid dendritic cells in stage III melanoma patients

Martine Bloemendal, Kalijn F. Bol, Steve Boudewijns et al. · OncoImmunology · 2021 · 25 citations · Full text

1–5 of 10